慢性阻塞性肺病患者的戒烟:双盲,安慰剂控制,随机化试验
D Tashkin1, R Kanner, W Bailey
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA School of Medicine, 90095, Los Angeles CA, USA. dtashkin@mednet.ucla.edu
持续释放布洛 (SR) 在患有慢性阻塞性肺病 (COPD) 的患者中显著增加了戒烟率. 这种有效的援助还减少了COPD吸烟者的烟草渴望和戒烟症状.
科学领域:
- 肺部病理学 肺部病理学
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
背景情况:
- 烟草吸烟是慢性阻塞性肺病 (COPD) 的首要原因,涉及80%以上的病例.
- 调查戒烟辅助剂对于管理COPD进展和改善患者的治疗结果至关重要.
研究的目的:
- 评估持续释放布洛 (SR) 作为在被诊断患有轻度至中度COPD的个体中戒烟工具的疗效.
- 评估布洛SR对吸烟戒断率和相关戒断症状的影响.
主要方法:
- 一项为期12周的双盲,随机化,安慰剂对照试验,涉及404名患有轻度/中度慢性肺炎的患者,每天吸烟≥15支.
- 参与者接受了布洛普SR (每天两次150毫克) 或安慰剂,以及戒烟咨询.
- 主要终点是第4至第7周之间持续戒烟,并在6个月后进行随访.
主要成果:
- 与安慰剂相比,布鲁SR显著改善了连续吸烟戒断率 (28%与16%相比,从第4至第7周,p=0.003).
- 在较晚的时间点 (4-12周和4-26周) 观察到布洛SR的戒断率更高.
- 布鲁SR有效地减轻了吸烟渴望和戒烟症状,并报告了良好的耐受性.
结论:
- 持续释放布洛 (SR) 是一种耐受性良好且有效的药物疗法,用于COPD患者戒烟.
- 布鲁SR提供了一种有价值的治疗选择,以支持轻度至中度COPD患者的戒烟努力.
更多相关视频
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
相关概念视频
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
